caffeine has been researched along with Amyloid Deposits in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stazi, M | 1 |
| Lehmann, S | 1 |
| Sakib, MS | 1 |
| Pena-Centeno, T | 1 |
| Büschgens, L | 1 |
| Fischer, A | 1 |
| Weggen, S | 1 |
| Wirths, O | 1 |
| Oulès, B | 1 |
| Del Prete, D | 1 |
| Greco, B | 1 |
| Zhang, X | 1 |
| Lauritzen, I | 1 |
| Sevalle, J | 1 |
| Moreno, S | 1 |
| Paterlini-Bréchot, P | 1 |
| Trebak, M | 1 |
| Checler, F | 1 |
| Benfenati, F | 1 |
| Chami, M | 1 |
2 other studies available for caffeine and Amyloid Deposits
| Article | Year |
|---|---|
Long-term caffeine treatment of Alzheimer mouse models ameliorates behavioural deficits and neuron loss and promotes cellular and molecular markers of neurogenesis.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Biomarkers; Caffeine; Cells, Cultured; Female; Ma | 2021 |
Ryanodine receptor blockade reduces amyloid-β load and memory impairments in Tg2576 mouse model of Alzheimer disease.
Topics: Alzheimer Disease; Aminophenols; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Prec | 2012 |